Showing 1 - 10 of 17
Persistent link: https://www.econbiz.de/10010848781
<Emphasis Type="Bold">Background: About 7% of children and adolescents are diagnosed with attention-deficit/hyperactivity disorder (ADHD) in the US. Patients with ADHD who are intolerant of or do not have an optimal response to stimulants often use non-stimulants as alternative therapies. Guanfacine extendedrelease...</emphasis>
Persistent link: https://www.econbiz.de/10011000747
Persistent link: https://www.econbiz.de/10011000750
The impairment associated with residual ADHD symptoms after stimulant therapy is becoming increasingly recognized. This is the first analysis of the cost effectiveness of stimulants combined with an adjunctive medication. This study suggests that the adjunctive therapy of GXR with stimulants is...
Persistent link: https://www.econbiz.de/10011001572
Conventional anticoagulants were most commonly used in the study sample. Under-monitoring and suboptimal care may be an issue for patients treated with warfarin. The average total inpatient cost of VTE-related hospitalizations is high. </AbstractSection> Copyright Springer International Publishing Switzerland 2014
Persistent link: https://www.econbiz.de/10011001687
Persistent link: https://www.econbiz.de/10014341073
This paper exploits longitudinal data and methods to study the determinants of child immunization in 1990s China. Many countries such as China are experiencing rapid economic transitions characterized by declining public health expenditures, privatizing health-care sectors, increased inequality...
Persistent link: https://www.econbiz.de/10008616538
Background:Background: About 7% of children and adolescents are diagnosed with attention-deficit/hyperactivity disorder (ADHD) in the US. Patients with ADHD who are intolerant of or do not have an optimal response to stimulants often use non-stimulants as alternative therapies. Guanfacine...
Persistent link: https://www.econbiz.de/10010585886
Background:Background: Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder in childhood, affecting 3-7% of school-age children in the US and imposing substantial economic burden. Stimulants are considered first-line pharmacological treatment and are the most...
Persistent link: https://www.econbiz.de/10010556689
This study suggests that hospitals can realize cost savings by substituting L-AMB for ABLC in the treatment of IFIs. The cost savings are driven by the lower rates of AEs associated with L-AMB use compared with ABLC. </AbstractSection> Copyright Springer International Publishing Switzerland 2014
Persistent link: https://www.econbiz.de/10011000708